Albert Labs International Corp.

As of September 30, 2023, Albert Labs International Corp. has 74.41M shares outstanding.

These figures are as of September 30, 2023.

As of September 30, 2023, Albert Labs International Corp. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2.29, indicating conservative leverage, while an interest coverage ratio of -15,489.21 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2023. Return on assets (ROA) is negative at -676.75, reflecting losses generated across the asset base.

As of the close on July 23, 2024, Albert Labs International Corp.'s stock has declined approximately 85.71% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.

These figures cover the twelve months ended September 30, 2023. Free cash flow yield is negative at -36.39: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -22.88, meaning Albert Labs International Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Albert Labs International Corp.'s most recent stock split took place on March 10, 2022 with a 10:1 split ratio.

As of September 30, 2023, Albert Labs International Corp. has an Altman Z-Score of -341.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.